RE:RE:RE:Yesterday’s N/RThe company does have $30- million in the bank, slow cash burn rate, established facilities in the Netherlands, and some revenues. It is probably a less than fair value market cap in my opinion. There is less and less speculation about psylocybin all the time. Share price should improve when the sector is back in favour. Right now oil/gas, lithium, and resources in general are hot in the markets. Correction for Tech, Crypto and Pharma by the looks of it. It always cycles. IMO
Buko